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Introduction {#sec1}
============

Gene expression is a universal process in all cells and consists of transcription, i.e., the synthesis of RNA based on the DNA, and---if RNA is not the final gene product---translation, i.e., the messenger RNA (mRNA)-guided synthesis of a protein. Since the late 1960s it has been known that the rates of transcription and translation are synchronized in *Escherichia coli (E. coli)* so that mRNA is translated while being transcribed ([@bib12]; [@bib30]; [@bib31]; [@bib37]; [@bib45], [@bib46]). This process, called transcription:translation coupling, is possible due to the lack of a physical barrier between transcription and translation in bacteria (reviewed in [@bib11]). Only recently, direct physical interactions between RNA polymerase (RNAP) and the ribosome have been demonstrated ([@bib13]; [@bib17]; [@bib22]), consistent with earlier observations that transcriptional events may control translation activity and vice versa ([@bib37]). As transcription and translation are closely connected to other central processes in a bacterial cell, such as DNA repair ([@bib36]) and protein folding ([@bib44]), transcription:translation coupling constitutes one of the key regulatory functions in bacterial gene expression.

However, there are also indications that transcription:translation coupling may involve a member of the family of N-utilization substance (Nus) G proteins, which serves as an adapter connecting RNAP and the lead ribosome ([@bib4], [@bib6]; [@bib41]; [@bib54]). *E. coli* NusG, member and eponym of the only universally conserved class of transcription factors ([@bib52]), consists of two domains, an N- and a C-terminal domain (NTD and CTD), respectively, connected via a flexible linker, which move independently ([@bib5]; [@bib33]). NusG-NTD binds RNAP and accelerates transcription elongation ([@bib8]; [@bib20]; [@bib33]). Structural studies demonstrate that NusG-CTD, which is a five-stranded, antiparallel β barrel with a Kyrpides-Ouzounis-Woese motif ([@bib24]), is a versatile interaction platform for various transcription factors. By binding to protein S10, which is part of the 30S subunit of the ribosome, NusG may link transcription and translation ([@bib4]). Saxena et al. also demonstrated specific 1:1 binding of NusG to 70S ribosomes both *in vitro* and *in vivo* ([@bib41]). S10 is identical with transcription factor NusE and forms a ribosome-free complex with NusB, NusA, and NusG which suppresses transcription termination ([@bib15]; [@bib19]; [@bib23]; [@bib40]; [@bib43]). Finally, NusG-CTD binds to termination factor Rho and is required for most Rho activity *in vivo* ([@bib4]; [@bib26]; [@bib32]). Transcription:translation coupling prevents Rho factor from terminating transcription by sequestering the NusG-CTD and by blocking Rho access to RNAP via untranslated mRNA. Cryptic *E. coli* Rho-dependent terminators located within open reading frames (orfs) are revealed when ribosomes are released by polar nonsense mutations ([@bib10]; [@bib35]).

Nevertheless, there is evidence for intragenic uncoupling and Rho-dependent transcription termination in the absence of nonsense mutations: [@bib49] and [@bib16] found that Rho resolves clashes between transcription and replication. Such conflicts are likely to occur within, rather than at the end of, genes. Uncoupling would allow Rho to release the stationary transcription elongation complexes (TECs).

Mutations in *nusE/s10* or *nusG* that uncouple transcription from translation increase sensitivity to chloramphenicol ([@bib41]). This antibiotic retards translation, breaking the bond between the lead ribosome and the TEC. Consequently, the uncoupled TEC may backtrack or terminate prematurely ([@bib16]).

In this report, we present a cryo-electron microscopy (cryo-EM) structure showing NusG binding to the S10 subunit in a 70S ribosome. The NusG-CTD binding site of S10 is also target of the ribosome-release factor, transfer-messenger RNA (tmRNA), raising the possibility that tmRNA might displace NusG at rare codons, thereby uncoupling transcription from translation ([@bib39]). We also show by solution-state nuclear magnetic resonance (NMR) spectroscopy that NusG, once bound to RNAP, can interact with S10 or with a complete ribosome, setting the structural basis for NusG-mediated coupling.

NusG couples transcription with translation *in vivo*, as proposed earlier ([@bib4]). Uncoupling of RNAP from the lead ribosome is enhanced when translation is compromised. Importantly, we demonstrate that uncoupled RNAP can outpace translation, leading to Rho-dependent transcription termination. This intragenic termination explains the necessity for the apparent perfect synchronization between transcription and translation ([@bib37]).

Results {#sec2}
=======

Structural Evidence of NusG Binding to the Ribosomal Protein S10 on the 70S Ribosome {#sec2.1}
------------------------------------------------------------------------------------

We assembled a NusG:70S complex by incubating 70S ribosomes with an excess of NusG and determined the structure of this complex by cryo-EM and single-particle reconstruction ([Table S1](#mmc1){ref-type="supplementary-material"}). Overall, 188,127 particles were extracted from 1,327 images and ∼5% of these particles showed an extra mass of density attached to the mass identified as protein S10 ([Figures 1](#fig1){ref-type="fig"}A and 1B). This additional density perfectly matches the size of NusG-CTD, suggesting that NusG binds at the site predicted from the solution NMR structure of NusG-CTD bound to the free ribosomal protein S10 in a 1:1 stoichiometry ([Figures 1](#fig1){ref-type="fig"}A and 1B \[[@bib4]\]). The density map reconstructed from the class of NusG:70S particles was refined to an average resolution of 6.8 Å. No density could be observed for NusG-NTD, indicating that it is flexibly bound to the NusG-CTD and does not interact with the ribosome.Figure 1Structure of NusG-CTD bound to 70S Ribosome(A) Cryo-EM density of the 70S ribosome:NusG complex (see also [Table S1](#mmc1){ref-type="supplementary-material"}). The density of the 50S subunit is shown in light blue, the density of the 30S subunit in yellow, the density corresponding to NusG-CTD in red.(B) Close-up view of the region boxed in (A). 70S (yellow), S10 (blue), and NusG-CTD (red) are in ribbon representation; cryo-EM density is shown as transparencies.(C) Superposition of the 70S:NusG complex with the 70S:tmRNA complex (tmRNA is in ribbon representation, purple and dark blue; EMD 5234, PDB: [3IZ4](pdb:3IZ4){#intref0025}). 30S and NusG-CTD are displayed as in (B).

During translation ribosomes may stall on incomplete mRNAs, i.e., they reach the 3′ end of an mRNA without terminating, resulting in an unproductive translation complex. Together with the small protein B (SmpB) tmRNA can bind to these stalled ribosomes in order to rescue them and to tag the nascent polypeptide chain for degradation in a process called trans-translation ([@bib51]). Interestingly, the NusG-CTD binding site overlaps with the region of S10 that is contacted by the tmRNA when it is bound to a ribosome in its resume state ([Figure 1](#fig1){ref-type="fig"}C \[[@bib4]; [@bib18]; [@bib38]; [@bib51]\]). From this we conclude that NusG-CTD and tmRNA share binding sites on S10, raising the possibility that, in addition to releasing stalled ribosomes, tmRNA competes with NusG for ribosome binding, thus preventing NusG from maintaining a linkage between the lead ribosome and RNAP. In other words, tmRNA might be able to displace NusG and thereby facilitate uncoupled transcription.

Simultaneous Binding of NusG to S10 and RNAP {#sec2.2}
--------------------------------------------

In the cryo-EM structure of *E. coli* NusG bound to a paused TEC ([@bib20]) only the density of NusG-NTD was observable, indicating that NusG-CTD moves freely and does not interact with RNAP. Binding of NusG-CTD to S10 was observed both in a binary system ([@bib4]) and a λN-dependent antitermination complex ([@bib23]; [@bib40]).

Since the NusG-CTD:S10 interaction is a prerequisite for NusG-mediated transcription:translation coupling, we probed this contact when NusG was bound to RNAP---but not in an antitermination context---by solution-state NMR spectroscopy. We employed NusG samples where \[^1^H,^13^C\]-labeled methyl groups of Ile, Leu, and Val residues in perdeuterated proteins served as NMR-active probes (\[ILV\]-NusG) to increase sensitivity, allowing us to study large systems.

In the methyl-transverse relaxation optimized spectroscopy (methyl-TROSY) spectrum of free \[ILV\]-NusG ([Figure 2](#fig2){ref-type="fig"}A), signals of the NusG-NTD and NusG-CTD perfectly superimpose with the signals of the isolated \[ILV\]-labeled protein domains, suggesting that the domains move independently, confirming a previous report stating that there are no intramolecular domain interactions ([@bib5]). Upon addition of RNAP in a two-fold molar excess, \[ILV\]-NusG signals were significantly decreased in the one-dimensional methyl-TROSY spectrum ([Figure 2](#fig2){ref-type="fig"}B, inset), indicating \[ILV\]-NusG:RNAP complex formation. Binding of RNAP increases the molecular mass of \[ILV\]-NusG dramatically, resulting in enhanced relaxation, which ultimately leads to drastic line broadening and a decrease in signal intensity. Interestingly, the two-dimensional spectra revealed a non-uniform signal decrease ([Figure 2](#fig2){ref-type="fig"}B), which is caused by a combination of several effects. First, there is a general loss of signal intensity due to the increase in molecular mass upon complex formation, as discussed above. Second, upon binding, methyl groups of Ile, Leu, and Val residues located in the binding surface come into close proximity of RNAP protons. Dipole-dipole interactions contribute to relaxation processes so that the signal intensity of these methyl groups is decreased more strongly than that of methyl groups located elsewhere in \[ILV\]-NusG. Finally, signal intensities may be affected by chemical exchange processes. We analyzed the signal intensity of \[ILV\]-NusG signals in the presence of RNAP quantitatively by calculating relative signal intensities, i.e., the ratio of the remaining signal intensity of \[ILV\]-NusG in the presence of RNAP to the signal intensity of free \[ILV\]-NusG ([Figure S1](#mmc1){ref-type="supplementary-material"}).Figure 2RNAP-Bound NusG Interacts with S10(A) Superposition of 2D \[^1^H, ^13^C\]-methyl-TROSY spectra of \[ILV\]-NusG (black, 20 μM), \[ILV\]-NusG-NTD (dark red, 100 μM), and \[ILV\]-NusG-CTD (light red, 30 μM).(B) 2D \[^1^H, ^13^C\]-methyl-TROSY spectra of \[ILV\]-NusG in the absence (black, 20 μM) and presence (orange, 18 μM) of two equivalents of RNAP. Inset: Normalized 1D \[^1^H,^13^C\]-methyl TROSY spectra, colored as 2D spectra. See also [Figure S1](#mmc1){ref-type="supplementary-material"}.(C) 2D \[^1^H, ^13^C\]-methyl-TROSY spectra of \[ILV\]-NusG alone (20 μM), in the presence of a 2-fold molar excess of RNAP (18 μM \[ILV\]-NusG), and upon titration of \[ILV\]-NusG:RNAP with 218 μM S10^Δ^:NusB. The molar ratio of \[ILV\]-NusG:RNAP:S10^Δ^:NusB is indicated in color. The panel on the right shows an enlargement of the boxed region. Selected signals are labeled and arrows indicate chemical shift changes upon S10^Δ^:NusB addition.(D) \[^1^H,^13^C\]-methyl-TROSY-derived normalized chemical shift perturbations of \[ILV\]-NusG-CTD methyl group signals of RNAP-bound \[ILV\]-NusG upon complex formation with S10^Δ^:NusB. Asterisks mark the values of individual methyl group signals, bars represent the highest values. Red bars indicate vanishing signals. Horizontal lines are thresholds for affected methyl groups: slightly affected (0.04 ppm ≤ Δδ~norm~ \< 0.07 ppm; black), moderately affected (0.07 ppm ≤ Δδ~norm~ \< 0.1 ppm; orange), and strongly affected (Δδ~norm~ ≥ 0.10 ppm; red).(E) Mapping of affected methyl groups on the structure of isolated NusG-CTD (left; PDB ID: [2JVV](pdb:2JVV){#interref65}) and NusG-CTD in complex with S10^Δ^ (right; PDB ID [2KVQ](pdb:2KVQ){#interref70}). NusG-CTD is shown in ribbon (gray), S10^Δ^ in ribbon and surface (blue) representation. Affected Ile, Leu, and Val residues are colored according to (D); non-affected Ile, Leu, and Val residues are gray. Side chains of Ile, Leu, and Val residues are depicted as sticks, their methyl groups as spheres. Strongly affected Ile, Leu, and Val residues are labeled. The orientation of NusG-CTD in the complex relative to the isolated state is indicated.

The average relative intensity of NusG-NTD signals was significantly lower than that of the linker or the NusG-CTD, suggesting that NusG-NTD binds to RNAP, whereas NusG-CTD remains flexible and moves independently, able to interact with other partners, as indicated by the NusG:TEC structure ([@bib20]). The signal intensity of all Ile, Leu, and Val residues in the RNAP binding site of NusG was completely extinguished, confirming that NusG-NTD binds to RNAP at its known binding site ([@bib14]; [@bib20]; [@bib23]; [@bib40]).

To test if NusG-CTD can bind to S10 while being tethered to RNAP via NusG-NTD, we titrated the \[ILV\]-NusG:RNAP complex with S10^Δ^ ([Figure 2](#fig2){ref-type="fig"}C). In order to increase stability, we used an S10 variant lacking the ribosome binding loop in complex with NusB ([@bib28]). Chemical shift changes of \[ILV\]-NusG-CTD signals upon titration of \[ILV\]-NusG:RNAP with S10^Δ^:NusB were determined ([Figure 2](#fig2){ref-type="fig"}D) and affected residues were mapped onto the three-dimensional structure of NusG-CTD ([Figure 2](#fig2){ref-type="fig"}E). Strongly affected residues are located in β strands 3 and 4 as well as in the connecting loop, in agreement with the binding site observed in the binary NusG-CTD:S10^Δ^ complex ([@bib4]). The loop between β strands 1 and 2 is also part of the NusG-CTD:S10^Δ^ binding site, but as it does not contain any Ile, Leu, or Val residues, no NMR-active probes are available in this region; nevertheless, affected residues can be found in β strand 1, directly preceding this loop. This suggests that the CTD:S10^Δ^ binding surface in the RNAP:NusG:S10^Δ^:NusB complex is identical to the one determined in the binary system. Importantly, the NusG-NTD signals do not change when S10^Δ^ is added to the NusG:RNAP complex, indicating that S10^Δ^ binding does not release the bound RNAP.

We conclude that the S10 interaction site of NusG-CTD is accessible in the NusG:RNAP complex and thus can promote ribosome binding and formation of a ribosome:NusG:RNAP complex.

To look for a ribosome:NusG:RNAP complex, we repeated the experiment using intact 70S ribosomes instead of S10^Δ^:NusB ([Figure 3](#fig3){ref-type="fig"}). In a first test, we titrated \[ILV\]-NusG with 70S ribosomes ([Figure 3](#fig3){ref-type="fig"}A). As in the \[ILV\]-NusG:RNAP experiment, signal intensity of \[ILV\]-NusG methyl groups was significantly, but not uniformly, decreased. In the presence of a 2-fold molar excess of ribosomes some NusG-NTD signals remained visible, whereas most NusG-CTD signals were nearly completely extinguished. Quantitative analysis of the \[ILV\]-NusG methyl group signal intensity in the presence of 0.5 equivalents of 70S ribosomes clearly shows that the relative intensity of NusG-CTD signals was in a narrow range \<2%, whereas the relative intensity of NusG-NTD signals covered values from 0%--4% and was higher on average ([Figure 3](#fig3){ref-type="fig"}B). Relative intensities of zero of NusG-NTD signals can be attributed to the fact that these signals are weak even in free NusG and can thus not be quantified upon ribosome binding. Owing to the flexibility of the linker, signals corresponding to amino acids in this region had the highest relative signal intensities. From these results we conclude that NusG binds to the ribosome via its CTD, in agreement with our cryo-EM structure ([Figure 1](#fig1){ref-type="fig"}). Owing to the drastic increase in molecular mass we were unable to determine a binding site from these experiments, but nevertheless, the pattern of intensity changes of NusG-CTD signals was similar to that resulting from the titration of RNAP-bound NusG with S10^Δ^, i.e., the most drastic decrease of signal intensity can be observed for residues 160--170, which are part of β strands 3 and 4 and the intervening loop. Consequently, we conclude that the ribosome binding site is identical with the binding site for isolated S10^Δ^.Figure 3RNAP-bound NusG Interacts with the 70S Ribosome(A and B) NusG interacts with 70S ribosome via its CTD. (A) 2D \[^1^H, ^13^C\]-methyl-TROSY spectra of free \[ILV\]-NusG (11 μM, black) and \[ILV\]-NusG in the presence of 70S ribosome (molar ratio \[ILV\]-NusG:ribosome = 1:0.5 (6.6 μM \[ILV\]-NusG, orange); = 1:1 (7.5 μM \[ILV\]-NusG, blue); = 1:2 (4 μM \[ILV\]-NusG, red)). Arrows indicate \[ILV\]-NusG-NTD signals that are well visible in the \[ILV\]-NusG:ribosome complex. (B) Quantitative analysis of \[ILV\]-NusG methyl group signal intensities in the presence of 0.5 equivalents of 70S ribosome. Relative signal intensities are plotted versus the sequence position of NusG. The domain organization of NusG is indicated above the diagram.(C) 2D \[^1^H, ^13^C\]-methyl-TROSY spectra of \[ILV\]-NusG (11 μM, black), \[ILV\]-NusG in the presence of RNAP (molar ratio 1:2, 6 μM \[ILV\]-NusG, blue), and \[ILV\]-NusG in the presence of RNAP and 70S ribosome (molar ratio 1:2:1, 6 μM \[ILV\]-NusG, red).(D) 2D \[^1^H, ^13^C\]-methyl-TROSY spectra of \[ILV\]-NusG^F165A^ (20 μM, black), \[ILV\]-NusG^F165A^ in the presence of RNAP (molar ratio 1:2, 6 μM \[ILV\]-NusG^F165A^, blue), and \[ILV\]-NusG^F165A^ in the presence of RNAP and 70S ribosome (molar ratio 1:2:1, 6 μM \[ILV\]-NusG^F165A^, red). The inset shows the normalized 1D spectra of the corresponding titration step.See also [Figure S2](#mmc1){ref-type="supplementary-material"}.

Next, we formed a complex of \[ILV\]-NusG and RNAP (molar ratio 1:2). The 2D methyl-TROSY spectrum of the complex revealed a decrease of signal intensities ([Figure 3](#fig3){ref-type="fig"}C) typical for NusG binding to RNAP (see [Figure 2](#fig2){ref-type="fig"}C), i.e., primarily NusG-CTD signals remained visible. When we then added one equivalent of 70S ribosomes nearly all \[ILV\]-NusG signals were diminished (e.g., the signal corresponding to I164, which is in the loop responsible for ribosome binding; [Figure 3](#fig3){ref-type="fig"}C). Strikingly, the spectrum differs from the spectrum of \[ILV\]-NusG in the presence of 70S ribosome ([Figure 3](#fig3){ref-type="fig"}A). These results can be explained by three scenarios: (1) NusG-NTD is bound to RNAP, NusG-CTD is bound to a ribosome, and the ribosome directly interacts with RNAP; (2) NusG-NTD is bound to RNAP, NusG-CTD is bound to the ribosome, but the ribosome does not interact with RNAP; (3) NusG-NTD is bound to RNAP, the ribosome directly interacts with RNAP, and NusG-CTD is free but is in the vicinity of the ribosome. To exclude the last scenario we repeated the experiment using a NusG variant, NusG^F165A^, in which F165, essential for ribosome binding ([@bib4]; [@bib21]), is substituted by an Ala. Having ensured that the amino acid substitution does not influence the structure of NusG ([Figure S2](#mmc1){ref-type="supplementary-material"}A) we tested in a control experiment \[ILV\]-NusG^F165A^ binding to S10^Δ^. Indeed, we detected no interaction ([Figures S2](#mmc1){ref-type="supplementary-material"}B and S2C). When we added 70S ribosomes to a preformed \[ILV\]-NusG^F165A^:RNAP complex (molar ratio 1:2), the spectrum corresponding to the \[ILV\]-NusG^F165A^:RNAP complex did not change significantly and, in particular, NusG-CTD signals remained visible, suggesting that the ribosome was not bound ([Figure 3](#fig3){ref-type="fig"}D). However, the general decrease in signal intensity indicates a direct RNAP:ribosome interaction. Thus, we conclude that NusG can serve as physical linker between ribosome and RNAP, although it remains elusive if a direct interaction between RNAP and a ribosome occurs in this NusG-coupled complex.

Translation Promotes NusG Attachment to TEC {#sec2.3}
-------------------------------------------

Chromatin immunoprecipitation (ChIP) analysis showed that NusG binds to TEC well after transcription and translation initiation ([@bib34]). Thus, we asked whether translation was, in fact, required for attachment of NusG to the TEC. To approach this question, we examined the effects of translation on NusG-mediated Rho-dependent termination within the *lac* operon ([Figure 4](#fig4){ref-type="fig"}A, [Table 1](#tbl1){ref-type="table"}) as NusG recruitment to the TEC is necessary for efficient Rho-dependent termination. Rho-dependent termination occurs within *lacZ* both *in vitro* ([@bib7]) and, upon the introduction of *lacZ* nonsense mutations, *in vivo* ([@bib1]; [@bib35]). Polarity was measured using a probe to *lacA*, comparing mRNA levels with or without treatment with the Rho inhibitor bicyclomycin (BCM). Wild-type (WT) cells revealed no detectable termination ([Table 1](#tbl1){ref-type="table"} and [Figure 4](#fig4){ref-type="fig"}A-I), which may be attributed to (1) sequestering of NusG-CTD by the ribosome, (2) binding of the ribosome to the nascent RNA, or (3) both. In all scenarios, however, the presence of the translating ribosome prevents Rho binding. We interfered with translation initiation by mutating the ribosome-binding site, i.e., the Shine-Dalgarno (SD) sequence ([Figure 4](#fig4){ref-type="fig"}A-II), or translation elongation by introducing six successive rare arginine codons at two different locations in *lacZ* ([Figure 4](#fig4){ref-type="fig"}A-III and IV). Introduction of two G to A mutations in the *lacZ* SD sequence prohibits translation initiation of *lacZ* ([Figure 4](#fig4){ref-type="fig"}A-II). *lacA* mRNA measurements gave a readthrough of 21%, indicating that Rho-dependent termination occurs, but was inefficient in the absence of translation of *lacZ* mRNA. Introduction of the six in-frame rare arginine residues at the +4 position of *lacZ* ([Figure 4](#fig4){ref-type="fig"}A-III and [Table 1](#tbl1){ref-type="table"}) allowed 27% readthrough, i.e., Rho-dependent termination is present but still inefficient if translation of *lacZ* mRNA is interfered with at early elongation. In contrast, introduction of the rare arginine residues 200 nucleotides (nt) from the start site of transcription ([Figure 4](#fig4){ref-type="fig"}A-IV and [Table 1](#tbl1){ref-type="table"}) resulted in high polarity, yielding \<1% readthrough. As efficient Rho-dependent termination requires NusG our results suggest that NusG binding to TEC occurs late and is dependent on translation.Figure 4Translation Is Required for NusG Recruitment to the TEC(A and B) Left: Organization of the *E. coli lac* operon in strains MDS42 (A-I; wild type *lacZ*), RSW1225 (A-II; mutant \[inactive\] *lacZ* SD sequence), RSW1245 (A-III; in-frame insertion of six rare Arg codons \[*arg6*\] at position +4 of *lacZ*), RSW1276 (A-IV; in-frame insertion of λ*cro* and six rare Arg codons at position +4 of *lacZ* \[equivalent to *arg6* being at position +200 of the gene\]), and RSW1297 (B; λ*nutL* site upstream of mutant *lacZ* SD sequence). *lacY* and *lacA* are only indicated for clarity. qPCR primers specific to the 3′ end of *lacA* (position indicated in A-I) were used to measure mRNA levels and thereby readthrough of *lacA* (see [Table 1](#tbl1){ref-type="table"}). Right: Schemes of possible effects on transcription:translation coupling and Rho-dependent termination within *lacZ*. A-I, top: Ribosomes are recruited in the early elongation phase, leading to a directly coupled RNAP:ribosome complex (left) or uncoupled transcription and translation (right). A-I, bottom: NusG is recruited in late elongation, resulting in a NusG-coupled complex with (left) or without (middle) direct RNAP:ribosome contacts, or modifying the pre-existing RNAP:ribosome complex without establishing an CTD:S10 interaction (right). A-II: Failure of NusG recruitment results in inefficient Rho-dependent termination and high *lacZ* readthrough. A-III: *arg6* stops the translating ribosome at position +4, whereas transcription elongation proceeds (left), resulting in ribosome dissociation and no NusG recruitment. Transcription proceeds and is only inefficiently terminated by Rho (right). A-IV: NusG couples transcription and translation (left) until *arg6* stops the ribosome at position +200 (middle), allowing efficient, NusG-stimulated Rho-dependent termination (right). (B) λ*nutL* recruits NusA, NusG, and the S10/NusB dimer, creating a Nus complex. NusG can thus support Rho-dependent termination.Table 1NusG Couples Late after Transcription InitiationStrain*lacZnutL*Fold Increase of RNA Level (BCM^−^)Fold Increase of RNA Level (BCM^+^)RT (%)MDS42wt--.25 ± 0.04.26 ± 0.0396 ± 19RSW1225SD^-^--.12 ± 0.03.56 ± 0.1021 ± 7RSW1245arg(6)---early--.13 ± 0.01.49 ± 0.0227 ± 2RSW1276arg(6)---late--\<.001 ± 0.002.12 ± 0.003\<1RSW1297SD^-^+.01 ± 0.006.59 ± 0.012 ± 1[^6]

To confirm the hypothesis that NusG failed to attach to TEC in the absence of translation, we asked if a complex comprising Nus factors A, B, and E (Nus complex) assembled at a λ *nutL* site was able to recruit NusG so that it associates with TEC. Accordingly, we introduced the λ *nutL* site just upstream of the flawed *lacZ* SD sequence and measured *lacA* mRNA level ([Figure 4](#fig4){ref-type="fig"}B and [Table 1](#tbl1){ref-type="table"}). Indeed, Rho-dependent termination was highly efficient, indicating that NusG had been recruited to TEC. Thus, counterintuitively, the Nus complex, which normally suppresses transcription termination in ribosomal (*rrn*) operons ([@bib15]; [@bib19]; [@bib43]) and, together with λN, on the phage λ chromosome, stimulates termination in this case.

We finally demonstrated that reduced termination efficiency in the mutant with the non-functional SD sequence was due to the failure of NusG recruitment to the TEC. In this assay we monitored Rho-dependent termination in a fusion construct that carries λ *cro,* the λ *nutR* site, the Rho-dependent λ *tR1* terminator, and a *lacZ* reporter, with *lacZ* expression being heat-inducible ([Figure 5](#fig5){ref-type="fig"}). Termination at the λ *tR1* site is poor when *cro* is translated, as seen with the *cro ms27* fusion ([Table 2](#tbl2){ref-type="table"} and [Figure 5](#fig5){ref-type="fig"}A-I. In the presence of an intact SD sequence we used *cro ms27*, where codon 27 carries a missense mutation so that the resulting protein is non-functional. The 3′ end of *cro* is adjacent to the λ *tR1* terminator, limiting the amount of free RNA available for Rho attachment if *cro* mRNA is translated. When λ *cro* carried an SD mutation translation initiation was ablated, but nevertheless there was significant termination at λ *tR1* ([Table 2](#tbl2){ref-type="table"} and [Figure 5](#fig5){ref-type="fig"}A-II). Formation of the Nus complex at λ *nutR* allows NusG recruitment and efficient termination. In the absence of NusB, the complex does not assemble and there is extensive readthrough at λ *tR1.*Figure 5NusG Can Be Recruited via a Nus ComplexGenetic constructs used to monitor NusG-mediated Rho-dependent termination are shown with the corresponding strains and their properties indicated on the right side. Transcription is started from the λ*pR* promoter, followed by WT-λ*cro* or λ*cro* carrying a missense mutation at codon 27 (λ*cro27*), a WT or mutant λ*nutR* site, the Rho-dependent terminator λ*tR1*, and a λ*cII::lacZ* transcriptional fusion with a corresponding SD site. All strains encode a temperature-sensitive λcI construct (λ*cIts*) to allow temperature-controlled induction of gene expression from the λ*pR* promoter. (A) Nus complex formation compensates the lack of an SD sequence. (B) *BoxA* mutation impairs NusG recruitment (C) Uncoupling by NusG-NTD. λ*N*^*+*^ strains listed in (B) further encode the λN protein; in (B-II) the non-functional λ*nutR* sequence was generated by the *boxA69* mutation; NusG-NTD for strains listed in (C) was supplied from plasmid pRM442. See also [Tables 2](#tbl2){ref-type="table"}, [3](#tbl3){ref-type="table"}, and [4](#tbl4){ref-type="table"}.Table 2NusG Coupling at *nutR* Requires NusBStrain*cronusB*β-Galactosidase Activity (BCM^−^) in Miller Unitsβ-Galactosidase Activity (BCM^+^) in Miller UnitsRT (%)9,743*ms27*+530 ± 3680 ± 578 ± 0.712,580*ms27*Δ890 ± 111,150 ± 1577 ± 1.49,739SD^-^+141 ± 3613 ± 2523 ± 1.19,976SD^-^Δ1,191 ± 171,290 ± 3692 ± 3.0[^7]

The *boxA69* mutation also reduces Nus complex formation at λ *nutR* and, like the *nusB*^−^ mutation, enhances readthrough of λ *tR1* ([Table 3](#tbl3){ref-type="table"} and [Figure 5](#fig5){ref-type="fig"}B). In this experiment, we suppressed termination at λ *tR1* with λ N antitermination factor instead of BCM. Finally, we showed that expression of *nusG-NTD*, which competes with NusG for binding to RNAP, enhances readthrough ([Table 4](#tbl4){ref-type="table"} and [Figure 5](#fig5){ref-type="fig"}C). Taken together, these results strongly support the idea that NusG can be supplied by the Nus complex assembled at λ *nutR* in the absence of translation, inducing Rho-dependent termination at λ *tR1*.Table 3*BoxA* Mutations Block NusG Coupling at *nutR*Strains*boxAnusB*β-Galactosidase Activity (λN^−^) in Miller Unitsβ-Galactosidase Activity (λN^+^) in Miller UnitsRT (%)10,673; 10,672++125 ± 1946 ± 2313 ± 0.310,675; 10,674*69*+1,212 ± 302,211 ± 8755 ± 2.510,678; 10,677+Δ2,874 ± 242,616 ± 103100 ± 4.410,680; 10,679*69*Δ1,896 ± 252,416 ± 8078 ± 2.8[^8]Table 4NusG-NTD Uncouples Transcription and TranslationStrain*nusG-NTDnusB*β-Galactosidase Activity (BCM^−^) in Miller Unitsβ-Galactosidase Activity (BCM^+^) in Miller UnitsRT (%)RSW1396--+247 ± 5862 ± 229 ± 0.6RSW1397++944 ± 31,013 ± 793 ± 0.7RSW1398--Δ2,013 ± 332,314 ± 5587 ± 2.5RSW1399+Δ2,360 ± 372,760 ± 15086 ± 4.8[^9]

Discussion {#sec3}
==========

Structural Basis of NusG-Mediated Transcription:Translation {#sec3.1}
-----------------------------------------------------------

We determined a cryo-EM structure of a NusG:70S complex showing binding of one molecule NusG per ribosome, consistent with previous results ([@bib41]). NusG binds to the S10 protein on the 30S subunit via its CTD as indicated by the study of isolated NusG-CTD and S10^Δ^ ([@bib4]); density for NusG-NTD was not observable, suggesting that it remains flexible. We must attribute the low occupancy of the NusG-CTD on the 70S ribosome in the cryo-EM experiment to weak binding adversely affected by the conditions of sample preparation. Notably, although tmRNA contacts the ribosome at various sites, the binding of NusG-CTD and tmRNA on S10 seems to be mutually exclusive. This suggests a model in which uncoupling at rare codons, at which tmRNA releases ribosomes, is promoted by tmRNA-induced release of NusG ([@bib39]). The freed NusG:TEC complex exposes the NusG-CTD and is then subject to Rho-dependent transcription termination. This model, however, requires that the affinity of tmRNA for S10 is higher than for the NusG-CTD:S10 interaction. This could be the subject of further studies. Alternatively, tmRNA binding to S10 might only occur once NusG-mediated coupling has been disrupted owing to ribosome stalling, allowing transcription to continue while tmRNA rescues the ribosome.

Simultaneous binding of NusG to S10^Δ^ and RNAP has been demonstrated by solution-state NMR studies, confirming the S10^Δ^ binding site on NusG-CTD as identified in a binary NusG-CTD:S10^Δ^ system ([Figure 2](#fig2){ref-type="fig"}) ([@bib4]). Moreover, we show that NusG can bind isolated RNAP and isolated 70S ribosome concurrently. Although this is not an actively transcribing and translating system, our data provide the first direct structural evidence consistent with NusG-mediated transcription:translation coupling. The flexibility of the linker between the NusG-NTD and the NusG-CTD permits these interactions.

The operon-specific *E. coli* NusG paralog, RfaH, likewise simultaneously binds S10^Δ^ and RNAP in the context of a paused TEC ([@bib6]; [@bib54]). RfaH, which also comprises an NTD and a flexibly connected CTD ([@bib3]; [@bib6]), uses the same binding sites as NusG to interact with RNAP and S10 ([@bib4], [@bib6]; [@bib20]; [@bib42]; [@bib54]). However, RfaH, unlike NusG, complexes with TEC early after transcription initiation, when TEC pauses at an operon polarity suppressor (*ops*) site, a representative of the *E. coli* consensus pause sequence ([@bib25]; [@bib47]). Located in the untranslated leader region of RfaH-controlled operons, *ops* is responsible for sequence-specific recruitment of RfaH ([@bib53]). Importantly, RfaH-dependent operons lack a consensus SD sequence. To initiate translation, RfaH recruits a ribosome to these mRNAs, making coupling essential for translation activation and efficient gene expression ([@bib6]). The binding modes of RfaH and NusG to RNAP and S10 are very similar, indicating that coupling as observed for RfaH can also be mediated by NusG and vice versa. However, once recruited, RfaH excludes NusG ([@bib20]), thus preventing intra-operon Rho-dependent transcription termination in RfaH-controlled operons (see [@bib2]).

Recruitment of NusG Requires Translation and Stimulates Rho-Dependent Termination {#sec3.2}
---------------------------------------------------------------------------------

We have confirmed the results of Mooney et al. that NusG binds to TEC only after significant RNA synthesis ([@bib34]). As postulated by these authors, binding depends on active translation of the mRNA. Thus, efficient Rho-dependent transcription termination, which requires the attachment of Rho to the NusG-CTD, does not occur at the end of an untranslated gene. We have shown that the failure of NusG to bind TEC is responsible for the absence of termination. Thus, placing a λ *nut* site at the start of the gene recruits NusG and restores termination. At present, it is not understood why NusG appears to be delivered to TEC by ribosomes *in vivo*, whereas it binds directly to RNAP in a purified system lacking ribosomes. A possible explanation would be that NusG attaches to RNAP discontinuously in an on-and-off mode in the untranslated leader region and that the NusG:RNAP interaction is only stabilized when the ribosome is coupled upon translation initiation. We should recall that NusG has two binding sites in the coupled system, which significantly increases its avidity.

Multiple Modes of Transcription:Translation Coupling {#sec3.3}
----------------------------------------------------

A direct connection between transcription and translation was first predicted in 1964 ([@bib9]), and later it was shown that transcription:translation coupling is necessary to coordinate gene expression as well as to maintain genome stability ([@bib29]). In 1970, Miller et al. performed electron microscopy analyses of lysed *E. coli* cells ([@bib31]). They demonstrated that all mRNA molecules are connected to the *E. coli* genome and that the ribosome at the newly synthesized end of a polyribosome is almost always immediately adjacent to the putative RNAP molecule. Finally, they concluded that translation is completely coupled with transcription. Coupling could allow RNAP to monitor the translation rate while providing newly synthesized mRNA to the ribosome. The structural basis of this coupling is, however, still only poorly understood. Our results strongly suggest that NusG may mediate coupling ("indirect coupling"). Since NusG attaches to the TEC downstream to the translation initiation site, the coupled transcription:translation complex must initially consist of a ribosome bound directly to TEC. This "direct coupling" mode is in agreement with both structural and biochemical data ([@bib13]; [@bib17]; [@bib22]). A cryo-EM structure of a directly coupled complex has been published where a translating ribosome collided into a stalled RNAP, forming a so-called expressome ([Figure 6](#fig6){ref-type="fig"}A \[[@bib22]\]). In this complex, RNAP directly binds to the 30S subunit with the RNA exit region of RNAP docking onto the ribosome near the mRNA tunnel entry between ribosomal proteins S3, S4, and S5, allowing the mRNA exiting from RNAP to enter directly into the ribosome. Another cryo-EM structure showed an RNAP:30S complex generated by mixing 30S subunit with a 3-fold excess of RNAP ([Figure 6](#fig6){ref-type="fig"}B \[[@bib13]\]). In this structure RNAP is bound to the 30S subunit near the mRNA binding site between the head and the platform domains, contacting ribosomal proteins S1, S2, S18, S21, and hairpin loop 40 of 16S rRNA, in agreement with cross-linking data ([@bib17]). Strikingly, this position is located more than 80 Å from the binding site observed in the expressome structure, i.e., on the opposite side of the 30S head. Importantly, it ensures that RNAP interacts with the cytosolic side of the 30S ribosomal subunit so that the nascent RNA exiting from RNAP is directly guided to the entry site on the ribosome. Assuming that both the RNAP:30S complex and the expressome correspond to active coupling complexes, the structures indicate that multiple coupling modes exist, which involve massive relocalization of RNAP relative to ribosome.Figure 6Structures of Coupled ComplexesStructures of the expressome (A) and an RNAP:30S complex (B) determined by cryo-EM. RNAP and ribosomal subunits are in surface representation, NusG is shown as ribbon. α~I~, orange; α~II~ green; β, cyan; β′, light violet; 30S, yellow; 50S, light blue; β′CH, pink; S10, dark blue. PDB IDs: expressome, [5MY1](pdb:5MY1){#intref0040} and [6O9J](pdb:6O9J){#intref0045}; RNAP:30S, [6AWD](pdb:6AWD){#intref0050}; NusG-NTD: [2K06](pdb:2K06){#intref0055}; NusG-CTD: [2JVV](pdb:2JVV){#intref0060}.

Interestingly, neither the RNAP:30S nor the expressome structures allow NusG- (or RfaH-) mediated coupling: the linker of NusG/RfaH is too short ([Figure 6](#fig6){ref-type="fig"}). However, as the cryo-EM structures suggest that the position of RNAP on the 30S subunit might be flexible, these structures could be snapshots of distinct situations during translation. Thus, we suggest that, at some distance downstream of the translation initiation site, NusG recognizes and enters the coupled complex, rearranging its structure.

While our manuscript was under review, two preprints have been published reporting several structures of coupled complexes from *E. coli* ([@bib48]; [@bib50]). Overall, the structures indicate that there are indeed various types of transcription:translation coupling modes, both direct and indirect coupling. The coupling mode depends on the length of the mRNA separating the RNAP active site and the ribosomal P-site and is determined by the position of RNAP relative to the ribosome. For example, the structure of the collided complex (see above \[[@bib22]\]) was confirmed, but this coupling mode may be relevant only under certain conditions or when the RNA spacer is very short. In NusG-coupled complexes ([@bib48]; [@bib50]) NusG bridges RNAP and ribosome with NusG-NTD contacting the RNAP at the expected binding site ([@bib20]) and NusG-CTD interacting with S10. This is similar to what was found for the binary NusG-CTD:S10 system ([@bib6]) and is in agreement with our data. As compared with the collided complex, RNAP is significantly rotated relative to the ribosome, but, interestingly, no stable contacts between RNAP and ribosome were observable ([@bib50]). However, more coupling modes are possible, emphasizing the complexity of the interplay between transcription and translation ([@bib48]; [@bib50]).

Conclusion {#sec3.4}
----------

In summary, multiple transcription:translation coupling modes exist. Based on our results, we hypothesize that direct coupling between the ribosome and TEC occurs during translation initiation and early elongation, whereas NusG-mediated coupling is established later in translation in *E. coli*. Notably, the transition between the different coupling modes requires significant rearrangement of the relative position of RNAP and ribosome, with NusG serving as additional anchor point to restrict the freedom of RNAP movement relative to the ribosome.

Coupling may synchronize transcription and translation; in particular, the leading ribosome may "push" RNAP to overcome transcriptional pauses while RNAP could "pull" the ribosome to prevent/escape translational pausing ([@bib48]). In NusG-coupled complexes the small transcription factor may serve as cushion, conferring the system the flexibility necessary to keep transcription and translation synchronized, even if these processes are regulated differently or occur at different rates.

Limitations of the Study {#sec3.5}
------------------------

(1)*RNA extraction efficiencies* are subject to some variability.(2)*Cryo-EM modeling:* (a) The accuracy of the atomic model is limited by the cryo-EM resolution and the low occupancy of NusG on the ribosome. With the current resolution of the map, it is impossible to identify any rearrangement of side chains involved in interactions that stabilize the formation of the NusG:70S complex. The limited resolution also has the consequence that we had to rely on the accuracy of published structures used in the fitting and docking. (b) Furthermore, we modeled the 30S subunit structure only, based on a published atomic structure, even though the 70S-NusG complex was visualized. However, there are only minor differences between the structures of the isolated and 50S-bound 30S subunit, and the geometry of NusG binding determined by the modeling should not be affected.(3)*NMR:* (a) We used isolated RNAP and isolated ribosome in our experiments, and, consequently, not an actively transcribing/translating system. Thus, we provide only structural evidence that NusG can link RNAP and ribosome in the absence of nucleic acids. The situation might, theoretically, be different *in vivo* (although this is not very probable). (Already indicated in the section "Structural basis of NusG-mediated transcription:translation.") (b) Although we find that NusG can serve as linker between RNAP and ribosome we cannot distinguish between two scenarios: (i) NusG links RNAP and ribosome without direct interactions between RNAP and ribosome and (ii) NusG links RNAP and ribosome, but RNAP and ribosome make direct contacts in this coupled complex (already indicated at the end of section "Simultaneous binding of NusG to S10 and RNAP").

Resource Availability {#sec3.6}
---------------------

### Lead Contact {#sec3.6.1}

Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Joachim Frank (<jf2192@cumc.columbia.edu>).

### Materials Availability {#sec3.6.2}

This study did not generate new unique reagents.

### Data and Code Availability {#sec3.6.3}

For the 70S:NusG complex visualized by cryo-EM, only the region of 30S:NusG-CTD was modeled for simplicity. Electron densities and the final atomic model for the 70S:NusG complex have been deposited in the Electron Microscopy Data Bank (EMDB) and the Protein Data Bank (PDB) with accession codes EMD-22143 and [6XE0](pdb:6XE0){#intref0015}.

Methods {#sec4}
=======

All methods can be found in the accompanying [Transparent Methods supplemental file](#mmc1){ref-type="supplementary-material"}.
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Document S1. Transparent Methods, Figures S1 and S2, and Table S1
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[^7]: Expression of *lac*Z was induced from a chromosomal *cII*::*lacZ* transcriptional fusion (λ*cIts-pR-cro-nutR-tR1-cII::lacZ*) by incubating at 42°C for 30 min. N9743 and N12580 carry a missense mutation at *cro* codon 27; N9739 and 9,976 have a G to C mutation in the *cro* SD sequence (SD^−^); N12580 and N9976 are deleted for *nusB*. Where indicated, BCM was added to 100 μg/mL prior to induction of *lacZ* expression. Readthrough (RT) was calculated from the ratio of β-galactosidase activity (in Miller units) in the presence or absence of BCM (BCM^+^ and BCM^−^, respectively). Miller units from ≥3 independent experiments were averaged.

[^8]: Expression of *lacZ* was induced from a chromosomal *cII*::*lacZ* transcriptional fusion (λ*cIts-pR-cro* (*SD*^*-*^) *-nutR-tR1-cII::lacZ*) by incubation at 42°C for 30 min. Strains N10672, N10674, N10677, and N10679 express λ*n*, which encodes the transcription termination inhibitor λΝ. *boxA69* and Δ*nusB* strain numbers are indicated in [Table 3](#tbl3){ref-type="table"}. RT was calculated from the ratio of β-galactosidase activity in the presence or absence of λN (λN ^+^ and λN ^-^, respectively). Miller units from ≥3 independent experiments were averaged.

[^9]: Expression of *lacZ* was induced from a chromosomal *cII*::*lacZ* transcriptional fusion (λ*cIts-pR-cro*(SD^−^)*-nutR-tR1-cII::lacZ*) by incubating at 42°C for 30 min. *nusG-NTD* expression was induced from the plasmid pRM442 *tac* promoter with 1 mM IPTG for 10 min prior to induction of *lacZ* in strains RSW1397 and RSW 1399. Strains RSW1396 and RSW1398 carried an empty vector (p*trc99A*) and were exposed to IPTG as above. Where indicated BCM was added to 100 μg/mL prior to induction of *lacZ*. RT was calculated from the ratio of β-galactosidase activity in the presence or absence of BCM (BCM^+^ and BCM^−^, respectively). Miller units from ≥3 independent experiments were averaged.
